The prevalence of micro-and macroalbuminuria was determined in Type 2 (non-insulin-dependent) diabetic patients, less than 76 years of age, attending a diabetic clinic during 1987. All eligible patients (n = 557) were asked to collect a 24-h urine sample for quantitative albumin analysis. Urine collections were obtained in 296 males and 253 females (96%). Normoalbuminuria were defined as urinary albumin excretion < 30 mg/24 h (n = 323), microalbuminuria as 31-299 mg/24 h (n = 151), and macroalbuminuria as > 300 mg/24 h (n = 75). The prevalence of macroalbuminuria was significantly higher in males (20%) than in females (6%), while the prevalence of microalbuminuria was almost identical in males (26%) and females (29%). The prevalence of arterial hypertension increased with increased albuminuria, being 48%, 68%, and 85% in patients with normoalbuminuria, microalbuminuria, and macroalbuminuria respectively. Prevalence of proliferative retinopathy rose with increasing albuminuria, being 2%, 5% and 12% in patients with normoalbuminuria, microalbuminuria, and macroalbuminuria respectively. Prevalence of coronary heart disease, based on Minnesota coded electrocardiograms, was more frequent in patients with macroalbuminuria (46%) compared to patients with microalbuminuria (26%) and patients with normoalbuminuria (22%). Foot ulcers were more frequent in microand macroalbuminuric patients, being 13% and 25%, respectively, compared to 5% in patients with normoalbuminuria. This cross-sectional study has revealed a high prevalence of microalbuminuria (27%) and macroalbuminuria (14%) in Type 2 diabetic patients. Patients with raised urinary albumin excretion are characterized by obesity, elevated haemoglobin A~c, increased frequency of arterial hypertension, proliferative retinopathy, coronary heart disease and foot ulcers. Thus, these findings suggest that urinary excretion of albumin should be monitored routinely in patients with Type 2 diabetes.
Recent longitudinal studies have revealed a cumulative incidence of proteinuria between 30 and 50% in Type 2 (non-insulin-dependent) diabetic patients of different ethnic origins [1] [2] [3] . Diabetic nephropathy is the single most important cause of end-stage renal disease in the western world, accounting for more than 25% of all endstage renal disease in the United States [4] . Approximately 50% of the diabetic patients with end-stage renal disease suffer from Type 2 diabetes [5, 6] . The cost of caring for patients with end-stage renal disease in the United States currently exceeds 0.8 billion US dollars per year for diabetic nephropathy alone and is rising rapidly. Ninetyseven percent of the excess mortality associated with Type 2 diabetes in the Pima Indians, has been found in patients with proteinuria [7] .
Mogensen et al. [8] have shown that raised urinary albumin excretion below the level of clinical albuminuria (Albustix), so-called microalbuminuria, predicts the development of persistent macroalbuminuria in patients with Type 2 diabetes. Follow-up studies in Type 2 diabetic patients have demonstrated that microalbuminuria is a strong predictor of all-cause mortality, mainly cardiovascular [8] [9] [10] .
The aim of this cross-sectional study was to determine the prevalence of micro-and macroalbuminuria in Type 2 diabetic patients below the age of 76 years, attending a diabetic clinic in Copenhagen, and to evaluate the relationship between urinary albumin excretion and arterial blood pressure, retinopathy, blindness, macroangiopathy and foot ulcers. The study was started in 1987 as part of a prospective study on the development of diabetic nephropathy, retinopathy and cardiovascular disease in relation to abnormal urinary albumin excretion rate. 
Subjects and methods

Subjects
We examined the records of all our diabetic patients (n = 2551) attending the outpatient clinic at Hvid0re Hospital in 1987. This revealed 642 patients of European origin below the age of 76 years with primary Type 2 diabetes. Diabetic patients were regarded as suffering from Type 2 diabetes if they were treated by diet alone, or diet combined with oral hypoglycaemic agents, or if they were treated with insulin and had an onset of diabetes after the age of 40 years and a body mass index (BMI) above normal ( > 25 kg/m 2 in females, > 27 kg/m 2 in males) at the time of diagnosis [11] . Insulintreated lean patients (BMI < 25 kg/m 2 in females, BMI < 27 kg/m a in males) had a glucagon test performed, and Type 2 diabetes was diagnosed if a stimulated C-peptide value was > 0.60 pmol/ml [11] . The glucagon/C-peptide test was carried out after an overnight fast. Blood samples for plasma C-peptide determination were obtained before and 6 min after an i. v. bolus injection of i mg glucagon (Novo, Bagsvaerd, Denmark) as described previously [12] . In 110lean diabetic patients the glucagon test was performed. Seventy diabetic patients were excluded, since the glucagon test showed a stimulated C-peptide value of less than 0.60 pmol/ml. The remaining 572 patients were invited to participate in the study. Fifteen patients were excluded, mainly due to disabling diseases such as dementia and sequelae of cerebro-vascular accidents (CVA), which made them unable to co-operate. All the remaining eligible patients (n = 557) were asked to collect a 24-h urine sample for analysis of albumin excretion; 549 patients (96%) complied. Table i shows the clinical data for these patients.
The experimental design was approved by the local ethical committee, and all patients gave their informed consent.
Methods
All participants were examined and interviewed by one of us (M-A G). The World Health Organization cardiovascular questionnaire [13] was used to assess past and present evidence of myocardial infarction, angina pectoris, CVA, transient cerebral ischaemic attack and peripheral vascular disease. Evidence of present or previous foot ulcers, present medication and smoking habits was also recorded. Smokers were defined as persons smoking more than one cigarette/cigar/pipe per day, all others being classified as non-smokers.
Arterial blood pressure was measured twice, on the right arm, after 10 min rest in the supine position. The measurements were carried out with a Hawksley random zero sphygmomanometer (Hawksley & Sons Ltd, Lancing, Sussex, UK), cuff size 25 x 12 cm in lean and 30 x 15 cm in obese patients. Diastolic blood pressure was recorded at the disappearance of the Korotkoff sounds (phase V). Arterial hypertension was diagnosed according to the World Health Organization's criteria, systolic blood pressure >160mmHg, and/or diastolic blood pressure _> 95 mm Hg, or if antihypertensive treatment was being prescribed.
A 12-lead ECG was recorded. The ECG was coded independently by two trained observers using the Minnesota codes [14] . Coronary heart disease was diagnosed if ECG showed signs of probable myocardial infarction (Minnesota-code1.1-2) or possible myocardial ischaemia (Minnesota-code 1.3, 4.1-4, 5.1-3 or 7.1).
Ophthalmoscopy through dilated pupils was carried out by the same observer (EL). Visual acuity was assessed through a pin-hole. Blindness was defined as a corrected visual acuity < 0.1 (6/60) in the best eye. f Systolic blood pressure, normoalbuminuria vs microalbuminuria; g Systolic blood pressure, normoalbuminuria vs macroalbuminuria; h Diastolic blood pressure, n ormoalbuminuria vs microalbuminuria
The 24-h urine volume was recorded and aliquots stored at -20~ until the albumin concentration was determined, within one month, by radioimmunoassay with a single antibody [15] . This assay has a sensitivity of 0.5 mg/1 and an interassay coefficient of variation of 9%. Sterility of urine was checked by quantitative culture. If bacterial growth was found, urine collection was repeated after treatment. Normoalbuminuria was defined as urinary albumin excretion rate _< 30 rag/24 h, microalbuminuria as urinary albumin excretion rate greater than 30 mg/24 h and less than 300 rag/24 h, and macroalbuminuria as urinary albumin excretion rate > 300 mg/24 h as defined at a previous consensus conference [161. Some patients with macroalbuminuria receiving antihypertensive treatment had albuminuria below 300 mg/24 h.
Venous blood samples were collected in the non-fasting state. Haemoglobin Alc concentration (normal range 4.1q5.1%) was measured by an isoelectric focusing method [17] . Serum creatinine concentration was assayed by a buffered kinetic Jaffe' method [18] .
BMI was calculated as: body mass index=weight(kg)/ height(m) 2.
Statistical analyses
Values are mean (SD) or median (range). For evaluating frequencies the chi-squared test was used. The complications studied are irreversible, or almost irreversible, and therefore their prevalence increases with time, except when modified by the excess mortality in patients with elevated urinary albumin excretion rate. To account for the effect of duration of disease in comparisons of complications we performed stratified Mantel-Haenszel analyses [19] , using intervals of known duration of diabetes of 0-4, 5-8, 9-12, 13-16, and 17-20 years. To indicate when Mantel-Haenszel analyses has been applied, a subscript MH is added to chi-square.
In comparison of continuous variables the Kruskal-Wallis test of variance was used in order to test for differences between the three groups. If differences were found, the Mann-Whitney test was used for comparison between two groups.
Multiple logistic regression analyses [20] were used to assess the association of various factors to the occurrence of albuminuria, and the occurrence of coronary heart disease. The multiple logistic regression analysis was performed with sex, age, known duration of diabetes, BMI, haemoglobin Ale, serum-creatinine, presence of coronary heart disease, systolic and diastolic pressures, presence of smoking, retinopathy and maculopathy, foot ulcers and intermittent claudication, transient cerebral ischaemic attack and CVA as independent variables, and normo-micro-and macroalbuminuria as the dependent variables. In the case of albuminuria where there are three ordinal categories, the cumulative logit model [20, section 6.3] has been used. An assumption of this model is that the odds ratio for normo-vs micro-and macroalbuminuria is the same as for normo-and micro-vs macroalbuminuria. The confidence intervals are based on the asymptotic standard error of the logarithm of the odds ratio. The significant variables were selected by a likelihood based forward stepwise method. A multiple logistic regression analysis was performed with the same variables as mentioned above (except presence of coronary heart disease which was ex-100" n=183 n=l18 n,=93 n=66 n=38
Known duration of diabetes (years) Fig.2 . Prevalence of coronary heart disease (based on ECG Minnesota codes) in relation to known duration of Type 2 (non-insulindependent) diabetes and level of urinary albumin excretion rate. X = normoalbuminuria, 9 = microalbuminuria, 9 = macroalbuminuria changed with urinary albumin excretion rate (rag/24 h)) as independent variables, and occurrence of coronary heart disease as the dependent variable.
Apvalue < 0.05 was considered significant.
Results
Our cross-sectional study showed a prevalence of microalbuminuria and macroalbuminuria of 27% and 14%, respectively ( Table 1 ). The prevalence of macroalbuminuria was four times higher in males compared to females (p < 0.001), while the prevalence of normo-and microalbuminuria was almost identical in males and females. Of the 151 patients with microalbuminuria, 51 patients had urinary albumin excretion rate > 100 mg/24 h. Patients with abnormal urinary albumin excretion rate had slightly longer known duration of diabetes and elevated haemoglobin Ale (p <0.001) as compared to the normoalbuminuric subjects. The anti-diabetic treatment was com~ parable in all three groups. BMI was higher in patients with microalbuminuria: 28.6 (SD 4.5) kg/m 2 and macro-albuminuria: 29.6 (5.4) kg/m 2 compared to patients with normoalbuminuria: 27.2 (4.8) kg/m 2 (p < 0.01). Figure 1 shows the relationship between known duration of diabetes and albuminuria. The prevalence of normoalbuminuria declined from 68% to 41% at 20 years duration of diabetes. The prevalence of microalbuminuria increased from 22 to 33%, and the prevalence of macroalbuminuria rose from 10 to 26% after a 20-year duration of diabetes.
Bacteriuria of more than 105 microorganisms per ml was rare in males (2%), but fairly common in females; 8%, 18% and 14% in normo-micro-and macroalbuminuria respectively.
The prevalence of arterial hypertension, antihypertensive treatment, and blood pressure levels in patients not receiving antihypertensive treatment are shown in Table 2 . The prevalence of arterial hypertension was high in all three groups, and increased with increasing albuminuria. Untreated systolic blood pressure was higher in patients with microalbuminuria and with macroalbuminuria compared to patients with normal albumin excretion (p < 0.001, Table 2 ). A slightly elevated diastolic blood pressure, in patients with microalbuminuria compared to normoalbuminuria, was also observed (p < 0.05). When adjustment for BMI, age, and sex was carried out systolic blood pressure remained significant (p < 0.001) while diastolic blood pressure failed (p = 0.07). Linear regression analysis, in patients not receiving antihypertensive treatment showed that systolic (r = 0.27, p < 0.001) and diastolic (r = 0.24,p < 0.01) blood pressure correlated with the urinary albumin excretion rate.
The prevalence of proliferative retinopathy rose with increasing urinary albumin excretion (p < 0.01, Table 3 ). Maculopathy was more frequent in patients with macroalbuminuria: 13% compared to patients with normoalbuminutia: 4% and patients with microalbuminuria: 5% (p <0.05). However, 55% of patients with macroalbuminuria did not suffer from retinopathy. Figure 2 shows the prevalence of coronary heart disease, based on ECG Minnesota codes, in relation to Serum creatinine and systolic blood pressure expressed as multiples of 10 units such that odds ratio is calculated for a 10 unit change in these variables. According to the model the same odds ratio applies for the comparison normo-vs micro-and macroalbuminuria as for normo-and micro-vs macroalbuminuria 659 presence of coronary heart disease were significantly, independently associated with albuminuria. A multiple logistic regression analysis was performed with the same variables as mentioned above (except presence of coronary heart disease which was exchanged with urinary albumin excretion rate (mg/24 h)) as independent variables and occurrence of coronary heart disease as the dependent variable. In Table 6 the odds ratio and 95% confidence interval are shown. In this analysis age, known duration of diabetes, transient cerebral ischaemic attack and a!buminuria were independently associated with the presence of coronary heart disease. To examine the sex effect stratified analyses were made for each sex, but for no variable was there a significant difference. There was, however a tendency towards a greater effect of the variables for males, i. e. larger male risk differences. Table 6 . Adjusted odds ratios (95% confidence interval) for coronary heart disease in Type2 (non-insulin-dependent) diabetic patients by means of multiple ordinal logistic analysis
Variable
Odds ratio Probability Age (10 years)
1.68 (1.35-2.10) < 0.001 Known duration of diabetes (1 year Age expressed as multiple of 10 units such that odds ratio is calculated for a 10 unit change in this variable known duration of diabetes and type of albuminuria. A higher prevalence of coronary heart disease and a significant increase with longer duration of diabetes was demonstrated in macroalbuminuric patients compared to patients with normoalbuminuria (p < 0.001) and microalbuminuria (p < 0.005, Fig. 2 and Table 4 ). Despite this difference in the prevalence of coronary heart disease, the World Health Organization cardiovascular questionnaires revealed no differences in the frequency of angina pectoris between the three groups. The prevalence of CVA, transient cerebral ischaemic attack and intermittent claudication was low, and not significantly different between the three groups. The past and present prevalence of foot ulcers was higher in patients with (25%) than without macroalbuminuria (p < 0.01, Table 4 ). No significant difference in the history of smoking was found, the frequency of current smokers being 39%, 38%, and 42% in patients with normoalbuminuria, microalbuminuria and macroalbuminuria, respectively. Multiple logistic regression analysis was performed with sex, age, known duration of diabetes, BMI, haemoglobin Ale, serum-creatinine, presence of coronary heart disease, systolic and diastolic pressures, presence of smoking, retinopathy and maculopathy, foot ulcers and intermittent claudication, transient cerebral ischaemic attack and CVA as independent variables, and normo-microand macroalbuminuria as the dependent variables. The odds ratio and 95% confidence interval, for variables with significant influence on albuminuria, are shown in Table 5 . Male sex, BMI, retinopathy, foot ulcer, haemoglobin Alo, serum-creatinine, systolic blood pressure and
Discussion
The definition of micro-and macroalbuminuria applied in our study is identical to that recommended recently at a consensus conference [16] . Our cross-sectional study revealed an overall prevalence of microalbuminuria of 27% and of macroalbuminuria of 14% in Type 2 diabetic patients less than 76 years of age. Our patients with raised urinary albumin excretion were characterized by a longer duration of diabetes, obesity, elevated haemoglobin Ale, increased prevalence of arterial hypertension, proliferative retinopathy and maculopathy, coronary heart disease and foot ulcers.
As our study was not a survey based on the general population, selection bias might have been a confounding variable. However, none of our patients were referred to the hospital due to microalbuminuria, because sensitive techniques for determining urinary albumin concentration were not available to the general practitioners or general hospitals in 1987. However, we cannot rule out the possibility of selective referral of patients with late complications, e.g. nephropathy, since 27% (16males/4 females) of our patients with macroalbuminuria had nephropathy at the time of referral. However, the prevalence of macroalbuminuria in relation to known duration of Type 2 diabetes agrees closely with the results obtained in two surveys based on the general population, revealing a prevalence of macroalbuminuria of 12% and 15%, respectively [21, 22] . An even higher prevalence of macroalbuminuria (21%) has been demonstrated in the Pima Indians [23] . Other ethnic groups, e. g. Blacks, Hispanics and Indians, also have a higher prevalence of raised urinary albumin excretion as compared to European patients [24] [25] [26] . We have no evidence suggesting that the patients who dropped out were unrepresentative of the group as a whole except those with raised albumin excretion rate (excess mortality).
If microalbuminuria is a predictor or a marker of progression to clinical albuminuria as originally suggested by Mogensen [8] , then its prevalence should be higher than that of macroalbuminuria early in the course of Type 2 diabetes. The present and the previous studies [8, 9, 22, 27] have clearly shown that this is the case. Ballard et al. [3] have demonstrated that the cumulative incidence of persistent proteinuria is 25% 20 years after the diagnosis of Type 2 diabetes. Persistent proteinuria was present in 8% of the patients even at the time of diagnosis. We found that 10% of our patients developed macroalbuminuria within the first 4 years of diabetes, a finding in close agreement with the results obtained in a study of 661 patients with Type 2 diabetes based on the general population [21] . Preliminary data from a kidney biopsy study indicate that all albuminuric Type 2 diabetic patients with diabetic retinopathy suffered from diabetic glomerulosclerosis, while the chance for a diabetic or non-diabetic glomerulopathy was 50% in albuminuric Type 2 diabetic patients without retinopathy [28] . The male predominance of proteinuric patients was more marked in our study as compared to previous investigations [3, 21, 22] .
Our study revealed a higher frequency of raised arterial blood pressure in patients with microalbuminuria and macroalbuminuria. This finding confirms and extends previous observations in Type 2 diabetes [9, 23, 27, 29] . Furthermore, 48% of the normoalbuminuric diabetic group had arterial hypertension, suggesting a high prevalence of essential hypertension. Raised blood pressure accelerates the development and the progression of nephropathy in Type 2 diabetic patients [30] [31] [32] . Arterial blood pressure thus seems to have a complex relationship with diabetic nephropathy -nephropathy raising blood pressure and blood pressure accelerating the course of nephropathy. Unfortunately, trials assessing the long-term impact on kidney function of effective antihypertensive treatment are still lacking in Type 2 diabetic patients with raised urinary albumin excretion rate.
Haemoglobin AI~ and BMI were both elevated in our diabetic patients with raised urinary albumin excretion as compared to the normoalbuminuric patients. Furthermore, multiple logistic regression analysis revealed that both variables emerged as predictors of albuminuria. Longitudinal studies have demonstrated that hyperglycaemia is a risk factor for the development of proteinuria in Type 2 diabetes [3, 33] . Long-term near-normal blood glucose concentrations may delay or even prevent the progression from microalbuminuria to macroalbuminuria in Type 1 diabetic patients [34, 35] . Randomized controlled trials evaluating this important issue are urgently needed in Type 2 diabetic patients.
Our study revealed an association between raised urinary albumin excretion rate and the prevalence of maculopathy and proliferative retinopathy, in agreement with previous observations [3, 9, 21, 27] . Of our patients with macroalbuminuria 55% were without retinopathy as compared to 62% and 60% of the diabetic patients investigated by Marshall etal. [27] and Schmitz et al. [9] . These findings are remarkable compared to Type 1 diabetic patients where only 1% of the proteinuric patients are without retinopathy [36] .
Longitudinal follow-up studies in Type 2 diabetic patients [8] [9] [10] and in non-diabetic subjects [37, 38] have shown that microalbuminuria is a strong predictor of allcause mortality, mainly cardiovascular. Our study revealed that age, known duration of diabetes and abnormal urinary albumin excretion rate were associated with co-M.-A. Gall et al.: Prevalence of complications in Type 2 diabetes ronary heart disease when a logistic regression analysis was applied on all measured variables. Mattock et al. [39] showed that the urinary albumin excretion rate was significantly associated with coronary heart disease morbidity in normo-and microalbuminuric Type 2 diabetic patients. Of his patients 21% showed electrocardiographic evidence of coronary heart disease as compared with 22% and 26% in our normoalbuminuric and microalbuminuric group, respectively. The present and the previous study [39] both revealed that electrocardiographic signs of coronary heart disease are approximately three to four times more frequent than symptoms (angina). Presence of autonomic neuropathy may contribute to this disparity. Conventional risk factors for cardiovascular disease cannot account for the association between elevated urinary albumin excretion and the cardiovascular mortality in Type 2 diabetic patients [40] .
In conclusion, the present and previous studies suggest that urinary albumin excretion should be measured routinely in the management of patients with Type 2 diabetes because raised values indicate a need for more frequent follow-up of diabetic complications, coronary heart disease, arterial hypertension, and glycaemic control.
